Rich Pharmaceuticals Inc

(RCHA)

By |

Profile

Rich Pharmaceuticals Inc is a United States based development stage biopharmaceutical company. It is focused on the development on RP-323 for the treatment of Hodgkin's lymphoma (HL), Acute Myelogenous Leukemia (AML), and to cause elevation of white blood cells in the patients depleted of these elements due to various conditions. RP-323 is a naturally occurring compound that has properties suited for the treatment of patients with HL, and AML. RP-323 has an ability to convert cancer cells to normal cells, a process called differentiation.

Contact Information

Website: www.richpharmaceuticals.com
Main Phone: +1 424 230-7001
Address: 9595 Wilshire Boulevard
Address 2: Suite 900
State: CA
City / Town: Beverly Hills
Country: USA
Postal Code: 90212

Issuer Information

Exchange: OTO
CEO: Ben Chang
Employees: 4
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 0.0001 $ 0. (0.00%)
Last Price 0.0001 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open 0.0002 High 0.0002 Low 0.0001 Prev Close 0.0001
Last Trade Volume 2 mi 52 Wk Hi 0.0008 52 Wk Low 0.0001
Market Cap 188,387 Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 1,883,867,821.00 EPS (TTM) -0.01 PE Ratio N/A Exchange OTCPK